To include your compound in the COVID-19 Resource Center, submit it here.

Signal deal leads Celgene into SERMs

Selective estrogen receptor modulators (SERMs) were all the rage a few years ago, with their promise of harnessing the benefits of estrogen modulation without the side effects of broad activity.

Read the full 307 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE